▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Jaguar Health (NASDAQ: JAGX)

$5.79

(0.5%)

$0.03

Price as of May 20, 2025, 3:54 p.m. ET

Jaguar Health Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
JAGX	-97.69%	-100.00%	-87.80%	-100%
S&P	+12.45%	+100.69%	+14.95%	+140%

Jaguar Health Company Info

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

News & Analysis

Featured Article

Why Jaguar Health Stock Skyrocketed 49% Today

The developer of plant-based medicines has a promising drug pipeline.

Joe Tenebruso | Jan 8, 2021

Valuation

Earnings Transcripts

Jaguar Animal Health (JAGX) Q2 2021 Earnings Call Transcript

JAGX earnings call for the period ending June 30, 2021.

Motley Fool Transcribing | Aug 13, 2021

Jaguar Animal Health (JAGX) Q1 2021 Earnings Call Transcript

JAGX earnings call for the period ending March 31, 2021.

Motley Fool Transcribing | May 19, 2021

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services